N-[(11bR)-2,6-Di-9-anthracenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide, 97%, 100mg

Dimethyl 1,8-Anthracenedicarboxylate>95.0%(GC)5g

2,5-Dichlorophenylthioethanol, 98.0%, 5g

Chromium(III) potassium sulfate dodecahydrate, min. 98%, pa, ACS, 250 g, plastic packaging.

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 10mg

1-Fmoc-4-Piperidone, 95.0%, 25g

Ethyl 2-amino-3-(4-methoxyphenyl)propanoate hydrochloride, 97%, 5g

n-Decane, min. 99%, for synthesis, 1L, glass packaging

Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-beta-D-glucopyranoside>98.0%(HPLC)5g

[(5-chloropyridin-3-yl)methyl](methyl)amine dihydrochloride, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 95.0%, 1g

(S)-6-Fluorochroman-4-amine hydrochloride, 95.0%, 250mg

8-((tert-Butoxycarbonyl)amino)octyl 4-methylbenzenesulfonate, 97%, 10g